Concepedia

Jeffrey Kang

JK

Statistics

Publications

5

Citations

185

H-Index

5

Active since

1978

Affiliations

Texas A&M University(Current)

Texas A&M Health Science Center

The University of Texas Southwestern Medical Center

University of Southampton

Jeffrey Kang is an author at Texas A&M University specializing in antibody engineering, pharmacy, and targeted therapy.

Publications per year

1978–2020

5

Publications

5

Engineering a HER2-specific antibody–drug conjugate to increase lysosomal delivery and therapeutic efficacy

Jeffrey Kang, Wei Sun, Priyanka Khare et al. · Nature Biotechnology · 2019 · 88 citations · Full text

, , +16

Engineering multivalent antibodies to target heregulin-induced HER3 signaling in breast cancer cells

Jeffrey Kang, Jayakumar Poovassery, Pankaj Bansal et al. · mAbs · 2013 · 28 citations · Full text

, , +17

Chromatin assembly in isolated mammalian nuclei

Earl R. Shelton, Jeffrey Kang, Paul M. Wassarman et al. · Nucleic Acids Research · 1978 · 28 citations · Full text

, , +15

Antibody targeting of <scp>HER</scp>2/<scp>HER</scp>3 signaling overcomes heregulin‐induced resistance to <scp>PI</scp>3<scp>K</scp> inhibition in prostate cancer

Jayakumar Poovassery, Jeffrey Kang, Dongyoung Kim et al. · International Journal of Cancer · 2014 · 28 citations · Full text

, , +17

An optimal “Click” formulation strategy for antibody-drug conjugate synthesis

Erol C. Vatansever, Jeffrey Kang, Alfred Tuley et al. · Bioorganic & Medicinal Chemistry · 2020 · 13 citations · Full text

, , +12

1–5 of 5